bioAffinity Technologies Says Japan Patent Office Intends To Grant Patent For CyPath Lung Cancer Test
Share
Why It Matters
BioAffinity got good news that Japan will approve a patent for their lung cancer test. This shows their tool is gaining respect in different countries around the world.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.